Optimizing the Use of the Gamma-Glutamyl Transpeptidase-to-Platelet Ratio and Transient Elastography to Identify Liver Cirrhosis in Patients with Chronic Hepatitis B Concurrent with Nonalcoholic Fatty Liver Disease
Table 1
Patients’ characteristics.
Characteristic
Standard value (range)
Patients ()
Age (years)
NA
Male gender (, %)
NA
123 (84.8%)
Body mass index (BMI) (kg/m2)
NA
Aspartate aminotransferase (U/L)
15-40
29 (25-36)
Alanine aminotransferase (U/L)
3-35
40 (29-58.5)
Total bilirubin (μmol/L)
4-23.9
12.9 (10.7-16.9)
Albumin (g/L)
36-51
Gamma-glutamyl transpeptidase (U/L)
10-60
32 (22-46)
Platelets count (103/mm3)
100–350
Prothrombin time activity (%)
70–120
Fasting glucose (mmol/L)
3.9-6.1
4.94 (4.64-5.37)
Total cholesterol (mmol/L)
3.1-5.7
4.84 (4.32-5.22)
Triglyceride (mmol/L)
0.34-1.92
1.21 (0.95-1.49)
HBeAg positive (, %)
>1
60 (41.4%)
HBV-DNA (log10 IU/mL)
<20 IU/mL
4.96 (3.68-6.71)†
Fibrosis score (METAVIR)
F0 (, %)
NA
25 (17.2%)
F1 (, %)
NA
48 (33.1%)
F2 (, %)
NA
29 (20.0%)
F3 (n, %)
NA
23 (15.9%)
F4 (, %)
NA
20 (13.8%)
Hepatic steatosis ≥5%
NA
62 (42.8%)
10-19%
NA
42 (29.0%)
≥20%
NA
41 (28.2%)
Data were expressed as means and standard deviations or medians and interquartile ranges (25th-75th). †Eighteen patients had undetectable HBV-DNA levels. NA: not applicable.
